Senseye: Partnering for Mental Health Innovation
Revolutionizing Mental Health Diagnostics
Senseye is developing the first AI-driven mental health diagnostic platform to transform how PTSD and other conditions are identified.
- Driven by Science: Senseye leverages AI-driven computer vision to analyze ocular biomarkers validated through clinical studies.
- Fast & Non-Invasive: Detects PTSD and related disorders in just 10 minutes using ocular and biometric data via smartphone.
- Objective & Reliable: Eliminates reliance on self-reported symptoms, ensuring accurate and data-driven diagnostics.
Value for Pharma Partners
Senseye enhances pharmaceutical clinical trials with cutting-edge AI diagnostics:
Accelerated Clinical Trials:
Faster recruitment with remote, AI-driven pre-screening.
Objective Endpoints:
Eliminates subjectivity, ensuring standardized and reliable trial data.
Real-Time Monitoring:
Remote tracking of patient status for optimized treatment.
Regulatory Alignment:
Progressing toward FDA authorization, aligning with regulatory expectations.